Aurora Private Wealth’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,376
Closed -$474K 178
2026
Q1
$474K Buy
+11,376
New +$466K 0.34% 72

Other funds holding BBC

Aurora Private Wealth's BBC Position: Q2 2026 in Review

Aurora Private Wealth sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q2 2026, closing a stake of 11,376 shares — an estimated $474K sold.

Aurora Private Wealth first reported a position in BBC in Q1 2026 and held it in 1 quarter. The position peaked at $474K in Q1 2026. 3 funds tracked by Wall St. Rank hold BBC as of Q2 2026.

  • Aurora Private Wealth reported no remaining Virtus Biotech Clinical Trials ETF position as of Q2 2026 after selling out during the quarter.
  • Aurora Private Wealth sold 11,376 Virtus Biotech Clinical Trials ETF shares in Q2 2026, an estimated $474K.
  • Aurora Private Wealth first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2026 and held it in 1 quarter.
  • Aurora Private Wealth's Virtus Biotech Clinical Trials ETF position peaked at $474K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2026.

Based on Aurora Private Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.